Jim Cramer Says You Should Sell These 10 Stocks
In this article, we discuss the 10 stocks that Jim Cramer says you should sell.
Posts Tagged ‘NASDAQ:EDIT’
10 Genomics Stocks in Cathie Wood’s Portfolio That Are Underperforming
In this article, we discuss 10 genomics stocks in Cathie Wood’s portfolio that are underperforming.
5 Stocks to Sell According to Motley Fool
Below is the list of 5 stocks to sell according to Motley Fool.
10 Stocks to Sell According to Motley Fool
In this article, we examined Motley Fool Asset Management's approach to investing in stocks. We also reviewed 10 stocks to sell according to Motley Fool.
Here is What Hedge Funds Think About Editas Medicine, Inc. (EDIT)
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity...
10 Best Genomics Stocks to Buy Now
In this article, we will discuss the 10 best genomics stocks to buy now.
Cathie Wood Portfolio: 5 Biggest Losers
In this article, we discuss the 5 biggest losers in the stock portfolio of Cathie Wood.
Hedge Funds Are Selling Editas Medicine, Inc. (EDIT)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
Cathie Wood’s Top 5 Small-Cap Stock Picks
In this article, we discuss Cathie Wood’s top 5 small-cap stock picks.
10 Best Up and Coming Stocks to Invest In
In this article, we discuss the 10 best up and coming stocks to invest in.
Hedge Funds Are Crazy About Editas Medicine, Inc. (EDIT)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
15 Fastest Growing Biotech Companies in the US
In this article we talk about 15 fastest growing biotech companies in the US.
Is EDIT A Good Stock To Buy Now?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Hedge Funds Have Never Been This Bullish On Editas Medicine, Inc. (EDIT)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Do Hedge Funds Love Editas Medicine, Inc. (EDIT)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Did Hedge Funds Drop The Ball On Editas Medicine, Inc. (EDIT) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Is Editas Medicine, Inc. (EDIT) Going to Burn These Hedge Funds?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Is Editas Medicine, Inc. (EDIT) A Good Stock To Buy?
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity...
Here is What Hedge Funds Think About Editas Medicine, Inc. (EDIT)
Is Editas Medicine, Inc. (NASDAQ:EDIT) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Is Editas Medicine, Inc. (EDIT) A Good Stock To Buy?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Is Editas Medicine, Inc. (EDIT) A Good Stock To Buy?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their ...
Top Performing Investor Adds Editas Medicine (EDIT), Sienna Biopharmaceuticals (SNNA) to Its Portfolio
You might have heard about Wildcat Capital Management and Leonard Potter before, although they are not as widely covered by financial websites like Warren Buffett, Carl Icahn, ...
3 Small-Cap Biotech Stocks That Could be Poised to Explode
With the threat of severe drug pricing regulations behind it for now, the biotech sector has launched a rally in recent days, with the iShares NASDAQ Biotechnology Index (ETF) (...
13D Filing: Polaris Venture Partners VI, L.P. and Editas Medicine Inc (EDIT)
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent...
10 Most Interesting Companies In The World
If you were to draw up a list of the most interesting companies in the world, what would it look like? What exactly makes a company interesting to other people? Perhaps it's the...
Here is What Hedge Funds Think About Editas Medicine Inc (EDIT)
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
13G Filing: Deerfield Management Reveals 5% Stake in Newly-Public Editas Medicine, Inc. (EDIT)
Form 13G's must be filed with the SEC upon any investor or entity amassing at least 5% of a company's outstanding shares, or alternatively, an investment falling beneath the 5...
13G Filing: Viking Global and Editas Medicine, Inc. (EDIT)
As a new 13G filing with the US Securities and Exchange Commission showed, Andreas Halvorsen's Viking Global holds a long position in Editas Medicine Inc (NASDAQ:EDIT).
Billionaire Andreas Halvorsen Buys Shares of New Public Company, Bill Gates’ Cascade Bullish on AutoNation Inc. (AN), and More
Although the hedge fund industry as a whole lost money in 2015, the top 20 hedge fund managers generated roughly $15 billion net of fees last year.
